化合物CNX2006 T6008
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1375465-09-0 | ¥1,330.00 | 询底价 |
25 mg | 1375465-09-0 | ¥2,280.00 | 询底价 |
1 mg | 1375465-09-0 | ¥298.00 | 询底价 |
5 mg | 1375465-09-0 | ¥778.00 | 询底价 |
50 mg | 1375465-09-0 | ¥3,320.00 | 询底价 |
1 mL | 1375465-09-0 | ¥946.00 | 询底价 |
2 mg | 1375465-09-0 | ¥438.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CNX-2006
描述: CNX-2006 是一种新型的不可逆突变选择性 EGFR 抑制剂,对 EGFRT790M 的IC50值小于 20 nM。
细胞实验: Cells with endogenous or transiently transfected mutant EGFRs (293 cells) are treated with inhibitors for 6 hours and then corresponding lysates are extracted and analyzed by immunoblotting.(Only for Reference)
激酶实验: Growth inhibition assays: Human EGFR mutant lung adenocarcinoma cell lines are treated with drugs in standard growth inhibition assays.
动物实验: Animal Models: Nude miceFormulation: 5% DMSO:15% Solutol HS15 in PBSDosages: 25 mg/kgAdministration: i.p.
体外活性: CNX-2006 is a novel irreversible EGFR tyrosine kinase inhibitor, specifically inhibits activating mutations of EGFR as well as the T790M mutation while having very weak inhibition at wild-type EGFR. In in vitro modeling of acquired resistance, continuous CNX-2006 treatment on drug-sensitive EGFR mutant cells leads to resistance more slowly than erlotinib. Dose escalation with CNX-2006 leads to differential effects in different lines, but does not select for T790M-mediated resistance. [1]CNX-2006 resistent cells shows increased expression of EMT markers and MMP9.[2]
体内活性: CNX-2006 is effective in H1975 (EGFR L858R/T790M) xenograft model. [1] [2]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMF : soluble
DMSO : 91 mg/mL(166.8 mM)
关键字: CNX-2006 | HER1 | inhibit | Epidermal growth factor receptor | ErbB-1 | Inhibitor | EGFR
相关产品: WS3 | Lapatinib | Withanolide A | Cetuximab | DZD1516 | CP-724714 | Ginsenoside Rh2 | CGP77675 | Sanguinarine chloride | Almonertinib mesylate
相关库: Cysteine Covalent Library | Anti-Prostate Cancer Compound Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Highly Selective Inhibitor Library | Target-Focused Phenotypic Screening Library
化合物CNX2006 T6008信息由TargetMol中国为您提供,如您想了解更多关于化合物CNX2006 T6008报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途